Simian adenoviruses as vaccine vectors
Replication incompetent human adenovirus serotype 5 has been extensively used as a delivery vehicle for gene therapy proteins and infectious disease antigens. These vectors infect replicating and non-replicating cells, have a broad tissue tropism, elicit high immune responses and are easily purified...
Main Authors: | Morris, S, Sebastian, S, Spencer, A, Gilbert, S |
---|---|
Format: | Journal article |
Published: |
Future Medicine
2016
|
Similar Items
-
Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016) -
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
by: Folegatti, P, et al.
Published: (2019) -
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
by: O'Hara, G, et al.
Published: (2012) -
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
by: Pedro M. Folegatti, et al.
Published: (2019-05-01) -
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
by: Gilbert, S, et al.
Published: (2017)